{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:07:52Z","timestamp":1789646872211,"version":"4.0.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010676","name":"Horizon 2020 Societal Challenges","doi-asserted-by":"publisher","award":["963845"],"award-info":[{"award-number":["963845"]}],"id":[{"id":"10.13039\/100010676","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cbi.2026.112153","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T15:08:36Z","timestamp":1779376116000},"page":"112153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A combined in silico and in vitro new approach methodology for early detection of liver steatogenic chemicals"],"prefix":"10.1016","volume":"435","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1275-9498","authenticated-orcid":false,"given":"Anouk","family":"Verhoeven","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Gadaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5624-8651","authenticated-orcid":false,"given":"Nisreen H.K.","family":"Isbaita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0877-429X","authenticated-orcid":false,"given":"Jian","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julen","family":"Sanz-Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Serrano-Candelas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6904-8833","authenticated-orcid":false,"given":"Rita","family":"Ortega-Vallbona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6685-7299","authenticated-orcid":false,"given":"Tamara","family":"Vanhaecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Vinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2026.112153_bib1","series-title":"New Approach Methodologies in Regulatory Science: Proceedings of a Scientific Workshop","year":"2016"},{"key":"10.1016\/j.cbi.2026.112153_bib2","series-title":"Silico Methods for Predicting Drug Toxicity","first-page":"521","article-title":"Adverse outcome pathways as versatile tools in liver toxicity testing","author":"Arnesdotter","year":"2022"},{"key":"10.1016\/j.cbi.2026.112153_bib3","article-title":"Adverse outcome pathway networks as the basis for the development of new approach methodologies: liver toxicity as a case study","volume":"40","author":"Vinken","year":"2024","journal-title":"Curr. Opin Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00204-025-04235-5","article-title":"Mechanism-based new approach methodologies for in vitro detection of chemical-induced liver steatosis","volume":"100","author":"Verhoeven","year":"2026","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153814","article-title":"A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: a case study on chemical-induced liver steatosis","volume":"505","author":"Verhoeven","year":"2024","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2026.112153_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nrd4309","article-title":"Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework","volume":"13","author":"Cook","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cbi.2026.112153_bib7","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1007\/s00204-020-02763-w","article-title":"The evolution of strategies to minimise the risk of human drug-induced liver injury (DILI) in drug discovery and development","volume":"94","author":"Walker","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib8","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(24)01811-7","article-title":"Steatotic liver disease","volume":"404","author":"Israelsen","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.cbi.2026.112153_bib9","article-title":"Epidemiology of non-alcoholic fatty liver disease and hepatocellular carcinoma","volume":"3","author":"Younossi","year":"2021","journal-title":"JHEP Rep."},{"key":"10.1016\/j.cbi.2026.112153_bib10","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0399-8320(04)95062-2","article-title":"H\u00e9patotoxicit\u00e9 des m\u00e9dicaments 14e mise \u00e0 jour du fichier bibliographique des atteintes h\u00e9patiques et des m\u00e9dicaments responsables","volume":"28","author":"Biour","year":"2004","journal-title":"Gastroenterol. Clin. Biol."},{"key":"10.1016\/j.cbi.2026.112153_bib11","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.cbi.2026.112153_bib12","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cbi.2026.112153_bib13","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1007\/s00204-020-02868-2","article-title":"Screening of repeated dose toxicity data in safety evaluation reports of cosmetic ingredients issued by the scientific committee on consumer safety between 2009 and 2019","volume":"94","author":"Gustafson","year":"2020","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10565-020-09537-1","article-title":"Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity","volume":"37","author":"Allard","year":"2021","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1126880","article-title":"Development of a reference and proficiency chemical list for human steatosis endpoints in vitro","volume":"14","author":"Kubickova","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cbi.2026.112153_bib16","series-title":"Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents","year":"2025"},{"key":"10.1016\/j.cbi.2026.112153_bib17","series-title":"Test No. 408: Repeated Dose 90-day Oral Toxicity Study in Rodents","year":"2025"},{"key":"10.1016\/j.cbi.2026.112153_bib18","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1038\/s41598-021-85708-2","article-title":"Performance of preclinical models in predicting drug-induced liver injury in humans: a systematic review","volume":"11","author":"Dirven","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2026.112153_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108082","article-title":"New approach methodologies in human regulatory toxicology \u2013 not if, but how and when","volume":"178","author":"Schmeisser","year":"2023","journal-title":"Environ. Int."},{"key":"10.1016\/j.cbi.2026.112153_bib20","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cbi.2006.12.003","article-title":"The human hepatoma HepaRG cells: a highly differentiated model for studies of liver metabolism and toxicity of xenobiotics","volume":"168","author":"Guillouzo","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2026.112153_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.yrtph.2017.02.017","article-title":"Quantitative weight of evidence to assess confidence in potential modes of action","volume":"86","author":"Becker","year":"2017","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154263","article-title":"A mechanistically-anchored and human stem cell-based in vitro test battery for assessing liver steatogenic potential of chemicals","volume":"518","author":"Verhoeven","year":"2025","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2026.112153_bib23","doi-asserted-by":"crossref","first-page":"D1180","DOI":"10.1093\/nar\/gkad1004","article-title":"The ChEMBL database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods","volume":"52","author":"Zdrazil","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.cbi.2026.112153_bib24","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13321-024-00917-x","article-title":"Quantitative structure\u2013activity relationships of chemical bioactivity toward proteins associated with molecular initiating events of organ-specific toxicity","volume":"16","author":"Gadaleta","year":"2024","journal-title":"J. Cheminf."},{"key":"10.1016\/j.cbi.2026.112153_bib25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1021\/acs.chemrestox.4c00453","article-title":"Predicting liver-related in vitro endpoints with machine learning to support early detection of drug-induced liver injury","volume":"38","author":"Garcia De Lomana","year":"2025","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/acs.chemrestox.5c00402","article-title":"Structure\u2013activity relationship of protein-mediated molecular initiating events of organ-specific toxicities","volume":"39","author":"Isbaita","year":"2026","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/1471-2105-14-257","article-title":"KNIME-CDK: workflow-driven cheminformatics","volume":"14","author":"Beisken","year":"2013","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.cbi.2026.112153_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154155","article-title":"DockTox: targeting molecular initiating events in organ toxicity through molecular docking","volume":"515","author":"Ortega-Vallbona","year":"2025","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2026.112153_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154210","article-title":"In vitro test battery for testing molecular initiating events in chemical-induced cholestasis","volume":"517","author":"Maerten","year":"2025","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2026.112153_bib30","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.bcp.2011.03.004","article-title":"Critical selection of reliable reference genes for gene expression study in the HepaRG cell line","volume":"81","author":"Ceelen","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.cbi.2026.112153_bib32","series-title":"Users' Handbook Supplement to the Guidance Document for Developing and Assessing Adverse Outcome Pathways: Series on Testing and Assessment No. 233 and Series on Adverse Outcome Pathways No. 1","year":"2018"},{"key":"10.1016\/j.cbi.2026.112153_bib33","article-title":"A comparative study of biostatistical pipelines for benchmark concentration modeling of in vitro screening assays","volume":"34","author":"Carstens","year":"2025","journal-title":"Comput. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib34","series-title":"Data Analysis, Machine Learning and Applications: Proceedings of the 31st Annual Conference of the Gesellschaft F\u00fcr Klassifikation e.V., Albert-Ludwigs-Universit\u00e4t Freiburg, March 7\u20139, 2007","year":"2008"},{"key":"10.1016\/j.cbi.2026.112153_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2025.102529","article-title":"Mitochondrial dysfunction in drug-induced hepatic steatosis: recent findings and current concept","volume":"49","author":"Borgne-Sanchez","year":"2025","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"10.1016\/j.cbi.2026.112153_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2022.101198","article-title":"Endoplasmic reticulum stress and lipids in health and diseases","volume":"89","author":"Celik","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.cbi.2026.112153_bib37","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2026.112153_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2016.04.007","article-title":"Advantageous use of HepaRG cells for the screening and mechanistic study of drug-induced steatosis","volume":"302","author":"Tolosa","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/toxsci\/kfx121","article-title":"Mechanistic toxicity tests based on an adverse outcome pathway network for hepatic steatosis","volume":"159","author":"Angrish","year":"2017","journal-title":"Toxicol Sci Off J Soc Toxicol"},{"key":"10.1016\/j.cbi.2026.112153_bib40","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1021\/acs.chemrestox.8b00112","article-title":"Adverse outcome pathway-driven analysis of liver steatosis in vitro : a case study with cyproconazole","volume":"31","author":"Luckert","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111283","article-title":"An adverse outcome pathway-based approach to assess steatotic mixture effects of hepatotoxic pesticides in vitro","volume":"139","author":"Lichtenstein","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib42","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1007\/s00204-021-02997-2","article-title":"More than additive effects on liver triglyceride accumulation by combinations of steatotic and non-steatotic pesticides in HepaRG cells","volume":"95","author":"Lasch","year":"2021","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00204-021-03182-1","article-title":"Investigating the in vitro steatotic mixture effects of similarly and dissimilarly acting test compounds using an adverse outcome pathway-based approach","volume":"96","author":"Alarcan","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib44","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00204-023-03490-8","article-title":"In vitro to in vivo extrapolation and high-content imaging for simultaneous characterization of chemically induced liver steatosis and markers of hepatotoxicity","volume":"97","author":"M\u00fcller","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252011154","article-title":"Computational strategies for assessing adverse outcome pathways: hepatic steatosis as a case study","volume":"25","author":"Ortega-Vallbona","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112153_bib46","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1007\/s00204-017-2045-3","article-title":"Adverse outcome pathways: opportunities, limitations and open questions","volume":"91","author":"Leist","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib47","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/toxsci\/kfw018","article-title":"Tipping the balance: hepatotoxicity and the 4 apical key events of hepatic steatosis","volume":"150","author":"Angrish","year":"2016","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2026.112153_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2021.117855","article-title":"An adverse outcome pathway based in vitro characterization of novel flame retardants-induced hepatic steatosis","volume":"289","author":"Negi","year":"2021","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.cbi.2026.112153_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116136","article-title":"In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays","volume":"449","author":"Evans","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib50","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.3390\/molecules25071616","article-title":"Computational study of drugs targeting nuclear receptors","volume":"25","author":"Kenda","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2026.112153_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10822-024-00550-8","article-title":"Rethinking the applicability domain analysis in QSAR models","volume":"38","author":"Mora","year":"2024","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.cbi.2026.112153_bib52","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1021\/jm050362n","article-title":"A critical assessment of docking programs and scoring functions","volume":"49","author":"Warren","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2026.112153_bib53","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s40246-024-00691-9","article-title":"Advancing understanding of human variability through toxicokinetic modeling, in vitro-in vivo extrapolation, and new approach methodologies","volume":"18","author":"Kreutz","year":"2024","journal-title":"Hum. Genom."},{"key":"10.1016\/j.cbi.2026.112153_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1632941","article-title":"Advancing human health risk assessment: the role of new approach methodologies","volume":"7","author":"Deepika","year":"2025","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115009","article-title":"Metabolomic-based assessment reveals dysregulation of lipid profiles in human liver cells exposed to environmental obesogens","volume":"398","author":"Franco","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib56","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00204-023-03649-3","article-title":"Impact of perfluoroalkyl substances (PFAS) and PFAS mixtures on lipid metabolism in differentiated HepaRG cells as a model for human hepatocytes","volume":"98","author":"Sadrabadi","year":"2024","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/toxsci\/kfv049","article-title":"Increased hepatic fatty acid uptake and esterification contribute to tetracycline-induced steatosis in mice","volume":"145","author":"Choi","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2026.112153_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.taap.2017.03.022","article-title":"Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis","volume":"324","author":"Bai","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib59","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00204-023-03450-2","article-title":"Determination of in vitro hepatotoxic potencies of a series of perfluoroalkyl substances (PFASs) based on gene expression changes in HepaRG liver cells","volume":"97","author":"Louisse","year":"2023","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib60","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-069X-14-13","article-title":"Non-monotonic dose-response relationships and endocrine disruptors: a qualitative method of assessment","volume":"14","author":"Lagarde","year":"2015","journal-title":"Environ. Health"},{"key":"10.1016\/j.cbi.2026.112153_bib61","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1053\/jhep.2003.50309","article-title":"Inhibition of microsomal triglyceride transfer protein: another mechanism for drug-induced steatosis in mice","volume":"38","author":"Lett\u00e9ron","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2026.112153_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.113860","article-title":"Valproic acid affects fatty acid and triglyceride metabolism in HepaRG cells exposed to fatty acids by different mechanisms","volume":"177","author":"Gr\u00fcnig","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib63","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1172\/JCI32752","article-title":"Inhibition of apolipoprotein B100 secretion by lipid-induced hepatic endoplasmic reticulum stress in rodents","volume":"118","author":"Ota","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cbi.2026.112153_bib64","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tem.2011.04.007","article-title":"Increased very low density lipoprotein (VLDL) secretion, hepatic steatosis, and insulin resistance","volume":"22","author":"Choi","year":"2011","journal-title":"Trends Endocrinol. Metabol. TEM"},{"key":"10.1016\/j.cbi.2026.112153_bib65","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bcp.2009.10.011","article-title":"Inhibition of hepatic carnitine palmitoyl-transferase I (CPT IA) by valproyl-CoA as a possible mechanism of valproate-induced steatosis","volume":"79","author":"Aires","year":"2010","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib66","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.3390\/ijms22095038","article-title":"In vitro liver toxicity testing of chemicals: a pragmatic approach","volume":"22","author":"Tabernilla","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2026.112153_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112129","article-title":"Mechanistic insights into impaired \u03b2-oxidation and its role in mitochondrial dysfunction: a comprehensive review","volume":"223","author":"Aqeel","year":"2025","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.cbi.2026.112153_bib68","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/toxsci\/kfae055","article-title":"Drug-induced impairment of mitochondrial fatty acid oxidation and steatosis: assessment of causal relationship with 45 pharmaceuticals","volume":"200","author":"Buron","year":"2024","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2026.112153_bib69","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3390\/antiox12091653","article-title":"Oxidative stress in liver pathophysiology and disease","volume":"12","author":"Allameh","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.cbi.2026.112153_bib70","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1007\/s00204-016-1925-2","article-title":"Hepatotoxic effects of cyproconazole and prochloraz in wild-type and hCAR\/hPXR mice","volume":"91","author":"Marx-Stoelting","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib71","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/cells9051192","article-title":"The connection of azole fungicides with xeno-sensing nuclear receptors, drug metabolism and hepatotoxicity","volume":"9","author":"Marx-Stoelting","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cbi.2026.112153_bib72","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1007\/s00204-019-02502-w","article-title":"Assessment of mixture toxicity of (tri)azoles and their hepatotoxic effects in vitro by means of omics technologies","volume":"93","author":"Seeger","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib73","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1111\/febs.12563","article-title":"Interaction of the antibiotic minocycline with liver mitochondria \u2013 role of membrane permeabilization in the impairment of respiration","volume":"280","author":"Sch\u00f6nfeld","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.cbi.2026.112153_bib74","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s11096-022-01397-5","article-title":"A pharmacovigilance study of the association between tetracyclines and hepatotoxicity based on Food and Drug Administration adverse event reporting system data","volume":"44","author":"Wei","year":"2022","journal-title":"Int. J. Clin. Pharm."},{"key":"10.1016\/j.cbi.2026.112153_bib75","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1516217","article-title":"Severe liver injury induced by minocycline in hepatitis B patient: a case report","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2026.112153_bib76","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1007\/s00204-025-04178-x","article-title":"Ontogeny of drug-induced fatty liver disease (DIFLD): from key initiating events to disease phenotypes","volume":"99","author":"L\u00f3pez-Pascual","year":"2025","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2026.112153_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118459","article-title":"Unravelling drug-induced hepatic steatosis: clinical sub-phenotypes, outcome prediction, and identification of high-concern drugs and hazardous chemical attributes","volume":"191","author":"Moreno-Torres","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.cbi.2026.112153_bib78","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fgene.2018.00396","article-title":"Analysis of time-series gene expression data to explore mechanisms of chemical-induced hepatic steatosis toxicity","volume":"9","author":"Aguayo-Orozco","year":"2018","journal-title":"Front. Genet."},{"key":"10.1016\/j.cbi.2026.112153_bib79","first-page":"167","article-title":"The long way from raw data to NAM-based information: overview on data layers and processing steps","volume":"42","author":"Blum","year":"2025","journal-title":"ALTEX"},{"key":"10.1016\/j.cbi.2026.112153_bib80","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1007\/s00204-023-03572-7","article-title":"Application of high throughput in vitro metabolomics for hepatotoxicity mode of action characterization and mechanistic-anchored point of departure derivation: a case study with nitrofurantoin","volume":"97","author":"Ramirez-Hincapie","year":"2023","journal-title":"Arch. Toxicol."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726002619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279726002619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T08:29:16Z","timestamp":1783067356000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279726002619"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":80,"alternative-id":["S0009279726002619"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112153","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combined in silico and in vitro new approach methodology for early detection of liver steatogenic chemicals","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2026.112153","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112153"}}